Second trimester abortion using intravaginal misoprostol.
Niromanesh
S
S
Mirza-Kochak-khan Hospital, Medical School, Tehran University of Medical Sciences and Health Services, Tehran, Iran. rmosavi@hotmail.com
Hashemi-Fesharaki
M
M
Mosavi-Jarrahi
A
A
D000020:Abortifacient Agents, Nonsteroidal / Q000008:administration & dosage* / Q000009:adverse effects; D000028:Abortion, Induced / Q000379:methods*; D000282:Administration, Intravaginal; D004107:Dilatation and Curettage / Q000706:statistics & numerical data; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D016595:Misoprostol / Q000008:administration & dosage* / Q000009:adverse effects; D011247:Pregnancy; D011262:Pregnancy Trimester, Second; D013607:Tablets; D013997:Time Factors
D000020:Abortifacient Agents, Nonsteroidal; D013607:Tablets; D016595:Misoprostol